The short answer is yes. But the evidence is more specific, and more informative, than the warning on the packet.
Understanding what smoking actually does to cancer risk -- which cancers, by how much, through what mechanism, and how that risk changes after quitting -- is more useful than a yes or no. It is information you can act on, rather than a fact that is easy to discount because it feels remote.
This article is not designed to frighten you. It is designed to be accurate.
How Smoking Causes Cancer -- The Biology
Cancer begins with DNA damage. When the DNA in a cell is altered in ways that remove normal growth controls, that cell can divide uncontrollably, invading surrounding tissue and spreading through the body. This is what cancer is, at the cellular level.
Cigarette smoke contains more than 70 confirmed carcinogens -- compounds that cause DNA damage directly. These include polycyclic aromatic hydrocarbons (like benzo[a]pyrene), nitrosamines (like NNK), benzene, and formaldehyde. Each cigarette delivers these compounds into the lungs, into the bloodstream, and through various pathways to tissues throughout the body.
The damage is cumulative. Not every DNA mutation produces cancer. The body has DNA repair mechanisms, and most mutations are repaired before they can cause problems. But smoking does two things that compound this: it causes DNA damage at a rate that exceeds normal repair capacity, and the compounds in smoke impair the repair mechanisms themselves.
Over years of exposure, damaged cells accumulate. The probability that one of those cells will develop into cancer increases with cumulative exposure. This is why cancer risk increases with both duration of smoking and number of cigarettes smoked -- and why reducing smoking quantity, though better than nothing, does not eliminate risk proportionally.
Which Cancers Are Linked to Smoking
Lung cancer is the most discussed smoking-related cancer, and for good reason -- approximately 85% of lung cancer cases are attributable to smoking in populations where smoking rates are substantial. But the list extends well beyond the lungs.
The International Agency for Research on Cancer (IARC), which is the authoritative body on cancer causation, classifies smoking as a cause of cancer at the following sites:
The lungs. The larynx (voice box). The oropharynx and hypopharynx (throat). The oesophagus. The stomach. The pancreas. The kidney and renal pelvis. The urinary bladder. The cervix. The myeloid leukaemia (a blood cancer). The liver. The colon and rectum. The nasal cavity and paranasal sinuses.
That is a substantial list. The reason the causal link extends this far is that carcinogens from smoke are absorbed into the bloodstream and delivered to tissues throughout the body. The bladder is particularly vulnerable because it stores urine, which concentrates tobacco carcinogens before excretion. The oesophagus is exposed directly. The pancreas and kidney receive carcinogens through blood supply.
Lung Cancer -- What the Numbers Mean
Approximately 1 in 10 men who smoke will develop lung cancer during their lifetime, based on population data from heavy-smoking cohorts. The absolute risk depends heavily on the number of cigarettes smoked per day and the duration of smoking -- what researchers call "pack-years."
Lung cancer has a low survival rate compared to many other cancers because it is typically diagnosed at a late stage, when symptoms appear. Early-stage lung cancer is largely asymptomatic. By the time a persistent cough, weight loss, or breathlessness develops, the cancer has often already spread.
This is not a reason to catastrophise -- it is a reason to understand that the benefit of quitting is most significant before symptoms ever develop. The reduction in risk from quitting accumulates over years in which the cancer has not yet formed.
How Smoking Risk Compares to Non-Smoking Risk
Population-level risk comparisons are one way to understand the magnitude of the smoking-cancer relationship.
The relative risk of lung cancer in current smokers compared to never-smokers is approximately 15 to 30 times higher, depending on smoking history and population studied. This is one of the strongest causal relationships in epidemiology -- comparable to the relationship between asbestos and mesothelioma, or HPV and cervical cancer.
For other cancers in the IARC list, the relative risks are lower but still clinically significant: approximately two to six times the baseline risk for bladder cancer, two to three times for oesophageal cancer, two times for kidney cancer, and so on.
These are relative risks -- they compare smokers to non-smokers. Whether they feel significant depends partly on what the absolute baseline risk is. For lung cancer, where the absolute risk in heavy smokers is meaningfully high, a 20-fold relative risk is genuinely alarming. For cancers with very low baseline rates, even a several-fold increase in relative risk may produce a modest absolute risk.
The IARC has been conservative in its classifications. A compound or exposure is not classified as a definite human carcinogen unless the evidence from human studies is convincing. The 15+ cancer types where smoking is listed as a definite cause reflect that level of certainty.
Risk Reduction After Quitting
One of the most clinically significant aspects of smoking-related cancer risk is that it decreases after cessation. The body does not treat past exposure as a permanent, fixed sentence.
The reason is cellular renewal. Most of the body's tissues are continuously replacing cells. Cells with DNA damage that have not yet become cancerous may be replaced by normal cells over time. The ongoing DNA damage from new carcinogen exposure stops. The DNA repair mechanisms, which smoking was impairing, begin recovering.
The timeline for risk reduction varies by cancer type.
For lung cancer, the major threshold is approximately ten years. After ten years smoke-free, lung cancer risk drops to roughly half that of a current smoker. This is one of the most consistent findings in cessation research. The risk continues to decline beyond ten years, though it does not return to the level of someone who never smoked.
For bladder cancer, risk reduction begins more quickly -- within a few years of cessation -- because the bladder's direct exposure to carcinogens in urine stops immediately when smoking stops.
For cancers where the mechanism involves systemic carcinogen exposure through blood, the timeline falls between these two. Generally, earlier quitting produces greater risk reduction, but meaningful reduction is documented even for people who quit in their 50s and 60s after decades of smoking.
Does Cutting Down Help?
Reducing smoking quantity reduces exposure and therefore reduces cancer risk compared to continuing at the same level. This is mathematically true.
But the relationship is not linear. Switching from 20 cigarettes per day to 10 does not halve cancer risk. The data suggests that cutting down without quitting produces smaller risk reductions than complete cessation. The carcinogens are still being delivered. The DNA damage is still accumulating, at a reduced rate.
There is also a compensatory behavior phenomenon: people who cut down often inhale more deeply or smoke more of each cigarette to compensate for reduced quantity. This can partially offset the nominal reduction.
The research on risk reduction strongly favours complete cessation over reduction as a strategy. Reduction is better than nothing. Cessation is significantly better than reduction.
Passive Smoking and Cancer
The link between secondhand smoke and lung cancer in non-smokers is established science, not a theoretical concern.
The IARC classifies secondhand smoke as a Group 1 carcinogen -- the highest certainty category. Non-smokers living with smokers have approximately a 20--30% increased risk of lung cancer compared to non-smokers in smoke-free environments. The absolute risk is lower than for direct smokers because the exposure is lower, but the carcinogens are the same.
For non-smoking partners of smokers, for children of smokers, this is relevant information -- not to produce guilt, but to frame the full picture of smoking's health effects.
What the Numbers Mean for You Specifically
Population statistics describe what happens to groups. They do not determine what will happen to any individual person. Many people smoke for decades and do not develop cancer. Some non-smokers do. Risk is not destiny.
What smoking does is increase the probability -- meaningfully, substantially -- that cancer will develop. What quitting does is decrease that probability -- also meaningfully, substantially -- relative to continuing.
The value of the information is not in producing anxiety. It is in making the decision to quit concrete. Abstract awareness that "smoking is bad for you" is easy to discount. Knowing that lung cancer risk approximately halves within ten years of quitting is information that has a timeline attached to it -- a trajectory that starts today if you quit today.
Milo tracks the milestones that are evidence of that trajectory: the cardiovascular improvements in the first year, the respiratory gains in the first months. The cancer risk reduction is on that same arc -- slower, but real.